Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Kamelopard AB
AB
Active
Org 5595156083
Lauritz Weibulls Väg 16, 224 65
Lund
Medical specialists activities
· NACE 8622
Est. 2025
1 employees
Watchlist
Share
Sweden
/
Companies
/
Medical specialists activities
/
Kamelopard AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
1M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
1M
2025
Income statement
SEK thousands
Item
2025
Revenue
1 326
Staff expenses
−650
EBITDA
632
Depreciation & amort.
—
EBIT
632
Net financials
0
Profit before tax
475
Tax
−98
Net profit
377
Balance sheet
SEK thousands
Item
2025
Total assets
871
Equity
402
Long-term debt
—
Short-term debt
311
Total debt
311
Financial ratios
5-year trend
EBITDA margin
47.6%
This company
15.8%
Market median
+201% vs market
2025
2025
Equity ratio
46.2%
This company
38.2%
Market median
+21% vs market
2025
2025
Return on equity
93.8%
This company
18.4%
Market median
+410% vs market
2025
2025
Net profit margin
28.4%
This company
8.1%
Market median
+251% vs market
2025
2025
Asset turnover
1.52×
This company
1.12×
Market median
+36% vs market
2025
2025
Debt / equity
1.16×
This company
0.62×
Market median
-87% vs market
2025
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-15 – 2025-12-31
View
PDF
More on Kamelopard AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
